Roche, the Swiss drug maker is optimistic about formulating drugs for Alzheimer's disease after it received promising results with a similar product from Biogen, a competitor.
Daniel O'Day, Pharmaceuticals head, said that Roche would look again at prospects for two of its experimental Alzheimer's drugs, which suffered setbacks in 2014, in the wake of recent data on Biogen's drug.
Donepezil may be Useful in Moderate-to-Severe Alzheimer’s Disease
Donepezil, which is currently used in mild-to-moderate cases of Alzheimer's disease, may be useful in severe cases as well, according to a recent study.
Advertisement
Alzheimer's medicine, aducanumab in a small trial showed a significantly slowed cognitive impairment in patients with mild symptoms, which is a rare bit of good news in the midst of high-profile failures from the likes of Pfizer and Eli Lilly.
Aducanumab similar to Roche's experimental product gantenerumab, blocks beta amyloid, a protein that forms toxic brain plaques, the underlying cause of Alzheimer's. Yet the results presented in Biogen's trial contrasts with a late-stage Phase III study with gantenerumab and Roche's Phase II drug crenezumab.
![Diet and Alzheimer´s Disease]( "Diet and Alzheimer´s Disease")
Alzheimer''s begins with forgetfulness, but over time affects speech and coordination along with drastic behavioral changes. The right diet may lower your risk by 40%. So isn''t a diet change worth it?
"We're not at a stage where we've made a final decision on those two programs, but we're encouraged because the data that was presented from Biogen showed a concordance between dose level, between plaque removal and between clinical effect," said O'Day.
Current drugs prescribed for Alzheimer's can do no more than ease some of the symptoms rather than delaying the progression of Alzheimer's unlike heart disease and cancer, which have seen major strides in drug development.
Source: Medindia
Diet and Alzheimer´s Disease
Alzheimer''s begins with forgetfulness, but over time affects speech and coordination along with drastic behavioral changes. The right diet may lower your risk by 40%. So isn''t a diet change worth it?
Advertisement
"We're not at a stage where we've made a final decision on those two programs, but we're encouraged because the data that was presented from Biogen showed a concordance between dose level, between plaque removal and between clinical effect," said O'Day.
Current drugs prescribed for Alzheimer's can do no more than ease some of the symptoms rather than delaying the progression of Alzheimer's unlike heart disease and cancer, which have seen major strides in drug development.
Source: Medindia
Music Therapy at Kalamazoo Alzheimer’s Facility Makes Patients Smile, Think Better
Residents gather in the dining room, sing songs, play instruments and get to know each other better. Music therapy is used in the treatment of memory loss.
Advertisement
 Antibodies That can Help Effectively Treat Alzheimer’s Disease IdentifiedA new study reports on the development of antibody treatments that can prevent the accumulation of a toxic protein, known as tau proteins, in the brain. | Advertisement
|
Advertisement
Recommended Reading
Latest Drug News
The CDSCO has approved the intravenous administration of AstraZeneca Pharma India's liver cancer drug, Tremelimumab Concentrate.
The FDA advises consumers not to use compounded medications as an alternative to known diabetic and weight reduction medications Ozempic, Rybelsus, and Wegovy.
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.